Study Information

Title: A Study Of Panobinostat In Children With Refractory Hematologic Malignancies External
Status: Recruiting participants
Conditions: Lymphoblastic Leukemia, Acute, Childhood; Myelogenous Leukemia, Acute, Childhood; Hodgkin's Disease; Non-Hodgkin's Lymphoma
Interventions: Drug: Panobinostat; Drug: Cytarabine; Drug: Panobinostat
Institutions: Dana-Farber Cancer Institute
Health Topics: Acute Lymphocytic Leukemia (ALL) in Adults, Acute Lymphocytic Leukemia (ALL) in Children, Acute Myeloid Leukemia (AML), Hodgkin Lymphoma, Non-Hodgkin Lymphoma

Contact Information


Dana Farber
Boston, MA